Faculdade de Medicina de Ribeirão Preto (FMRP) da USP

What Faculdade de Medicina de Ribeirão Preto (FMRP) da USP does

Faculdade de Medicina de Ribeirão Preto (FMRP), founded in 1952 as part of the University of São Paulo, is a public medical school and biomedical research center operating within Brazil's government university system. The institution delivers undergraduate programs in Medicine, Biomedical Sciences, and Physical Therapy, plus graduate and medical residency training, anchored by the 38,205 m² Monte Alegre campus in Ribeirão Preto. FMRP runs the Complexo Acadêmico de Saúde, which integrates teaching, the Hospital das Clínicas teaching hospital, the Hemocentro de Ribeirão Preto blood center network, and research centers including the Centro de Terapia Celular (CTC-USP) and Núcleo de Terapia Avançada (Nutera RP).

Core technology and research output center on cellular therapy: FMRP-Hemocentro researchers, in partnership with Instituto Butantan, have developed CAR-T cell therapy for leukemia and lymphoma with reported clinical efficacy above 87%, alongside CAR-NK-92 cell therapy protocols that have been internationally recognized and patented. The Hemocentro RP network operates as a regional blood platform, collecting, processing and distributing hemocomponents to approximately 130 hospitals across nine regions of São Paulo state, serving 249 municipalities and roughly 7 million people, with 119,442 transfusions and 242,132 hemocomponents distributed in 2025. Adjacent capabilities include an AI Laboratory for medical imaging at CCIFM, post-doctoral virology work with CNPEM, and precision oncology research coordinated through the INCT-TOP network that FMRP-Hemocentro hosts.

Revenue mechanics are non-commercial and government-funded: FMRP charges no tuition, delivers clinical services through the Brazilian public healthcare system (SUS), and finances research via grants from FAPESP, CNPq, CAPES and FINEP, with administrative support routed through the affiliated FAEPA foundation. Service distribution is via Hospital das Clínicas (specialist referrals across the region), Hemocentro RP (130+ hospitals across the state), and the national vestibular admissions system for undergraduates. Customer segments are medical and graduate students, SUS-referred patients, and government and grant-funder counterparties. Strategic emphasis has shifted toward commercializing CAR-T and CAR-NK platforms, including a 2024 international co-development agreement with Chinese biopharma IASO Bio and ANVISA engagement for SUS inclusion.

Name

Faculdade de Medicina de Ribeirão Preto (FMRP) da USP

Legal name

Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

Website

https://fmrp.usp.br

Company type

Public

Founded year

1952

Operating status

Operating

Headcount range

51–100 employees

Short description

Faculdade de Medicina de Ribeirão Preto (FMRP) is a public medical school of the University of São Paulo delivering medical education, SUS-funded healthcare through Hospital das Clínicas, and biomedical research including CAR-T cell therapy and a regional blood-banking network serving São Paulo state.

Ownership category

akta.pro rank

Product category

Medical Education and Academic Healthcare

NAICS

Colleges, Universities, and Professional Schools (6113), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Research Support (CRC/CTA) (EDAOAJAO), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Medical education
• Biomedical research
• Cellular therapy
• Blood banking services
• Public healthcare services

Headquarters

HQ city

Ribeirão Prêto

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Others

Distribution channels3 records

Marketing channels5 records

Core offering

Faculdade de Medicina de Ribeirão Preto (FMRP) is a public medical school within the University of São Paulo that delivers tuition-free undergraduate medical education (Medicine, Biomedical Sciences, Physical Therapy), graduate and residency training, and operates a large teaching hospital (Hospital das Clínicas). It also runs the Hemocentro blood center network covering one-third of São Paulo state and conducts advanced biomedical research, including proprietary CAR-T and CAR-NK cellular therapies developed with Instituto Butantan.

Product overview

Faculdade de Medicina de Ribeirão Preto (FMRP-USP) is a medical school affiliated with the University of São Paulo, operating as part of the Complexo Acadêmico de Saúde (Health Academic Complex) alongside Hospital das Clínicas, Hemocentro de Ribeirão Preto, and other affiliated institutions. The institution offers undergraduate programs in Medicine, Biomedical Sciences, and Physical Therapy, along with graduate programs and medical residency. Its research infrastructure includes the Centro de Terapia Celular (CTC-USP) and Núcleo de Terapia Avançada (Nutera RP) for advanced cellular therapies, the Hemocentro blood center network, academic journals, and educational platforms like e-Disciplinas USP. The institution does not operate commercial software products but develops therapeutic technologies including CAR-T cell therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Undergraduate Medical and Biomedical Sciences Programs Tuition-free undergraduate programs in Medicine, Biomedical Sciences, and Physical Therapy offered through the Comissão de Graduação (CG) of FMRP-USP. Admitted via the national university entrance examination (vestibular) and aimed at students seeking medical and health sciences education in Brazil.
• Graduate Programs (Master's and Doctoral) and Medical Residency Postgraduate stricto sensu programs (master's, doctoral) and lato sensu medical residency training delivered through the Comissão de Pós-Graduação (CPG) and Hospital das Clínicas. Targets graduate students, researchers, and medical residents.
• Hospital das Clínicas da FMRP-USP (Teaching Hospital Services) Large teaching hospital providing specialized SUS-reimbursed tertiary medical care, clinical residency training, and a platform for clinical research. Targets individual patients referred through the Brazilian public healthcare system and medical residents seeking training.
• Hemocentro de Ribeirão Preto (Blood Center Services) Public blood center providing blood collection, processing, testing, storage, and distribution services for transfusion medicine. Distributes hemocomponents to approximately 130 hospitals across São Paulo state, with 119,442 transfusions performed in 2025 and 242,132 hemocomponents distributed.
• Rede Hemocentro de Ribeirão Preto (Blood Distribution Network) Coordinated regional network of blood centers and transfusion agencies in Araçatuba, Batatais, Bebedouro, Fernandópolis, Franca, Olímpia, Presidente Prudente, Taubaté, Ribeirão Preto (two units), and Jales. Covers nine regions of São Paulo state, serving 249 municipalities and approximately 7 million people.
• CAR-T Cell Therapy Clinical Program (Nutera RP / CTC-USP) Cellular therapy clinical program offering investigational CAR-T cell therapy for leukemia and lymphoma (B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma), with over 87% efficacy demonstrated in clinical trials. Developed in partnership with Instituto Butantan under the CARTHEDRALL study and under ANVISA review. Targets oncology patients in the SUS.
• CAR-NK Cell Therapy Research Program Research and clinical development program for CAR-NK-92 cell therapy for hematological cancers, recognized internationally with patented protocols developed by Hemocentro RP. Targets oncology patients and serves as the foundation for new advanced therapy agreements (e.g., with IASO Bio).
• Meu Hemocentro RP Mobile App Mobile application for blood donors and the public to schedule blood donations, receive reminders, view campaign information, and track donation history. Available on iOS App Store and Google Play Store. Targets blood donors and prospective donors across São Paulo state.
• Revista Medicina (Ribeirão Preto) Academic Journal Peer-reviewed academic journal published by FMRP-USP covering medical research, clinical studies, and biomedical advances. Distributed nationally and targets researchers, clinicians, and medical students.

Quantifiable outcome

• Over 87% efficacy in CAR-T cell therapy clinical trials for leukemia and lymphoma
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Instituto ButantancoreStrategic or Co-development Partner · 17 June 2022Strategic partnership for the development of CAR-T cell therapy for the treatment of leukemia and lymphoma. The collaboration combines USP/FMRP research capabilities with Butantan's clinical trial infrastructure and regulatory expertise. The therapy has shown over 87% efficacy in clinical trials and is being prepared for approval by ANVISA for inclusion in SUS.
• CNPEM (Centro Nacional de Pesquisa em Energia e Materiais)coreStrategic or Co-development PartnerPartnership with CNPEM provides postdoctoral fellowship opportunities in virology research, combining FMRP's medical research expertise with CNPEM's advanced scientific infrastructure.
• IASO BiominorStrategic or Co-development PartnerChinese biopharmaceutical company partnership formalized in April 2024 for the development of new advanced therapies against hematological cancers. The agreement was formalized during an event at Instituto Butantan.
• INCT-TOP (Instituto Nacional de Ciência e Tecnologia em Terapia Oncológica de Precisão)coreStrategic or Co-development PartnerInterdisciplinary research network involving basic science, pre-clinical, and clinical researchers focused on discovering new therapeutic targets, developing personalized therapies, and implementing innovative precision medicine strategies. FMRP-Hemocentro is the host institution.
• FAEPA (Fundação de Apoio ao Ensino, Pesquisa e Assistência)coreStrategic or Co-development PartnerSupport foundation that assists teaching, research, and healthcare assistance activities at HCFMRP-USP. Provides administrative and financial support for projects and manages institutional resources.
• Rede Hemocentro de Ribeirão PretocoreStrategic or Co-development PartnerNetwork comprising hemocenters in Araçatuba, Batatais, Bebedouro, Fernandópolis, Franca, Olímpia, Presidente Prudente, Taubaté, Ribeirão Preto (two units), and a transfusion agency in Jales. Serves 249 municipalities and approximately 7 million people.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Memorial Sloan Kettering Cancer Center: Elite academic cancer center with leading cellular therapy and CAR-T clinical trial programs, comparable in translational research output and the gold standard for oncology research with which FMRP's programs can be benchmarked.
• Hospital Israelita Albert Einstein: Brazil's leading private hospital with strong clinical research and residency programs. Comparable in research output and clinical sophistication, but operates under a private, SUS-participating model rather than a public university structure.
• Hospital Sírio-Libanês: Major private São Paulo hospital with significant research and graduate medical education programs, comparable in translational research and clinical excellence but operating privately.
• Instituto Butantan: Strategic partner of FMRP on CAR-T development, and a much larger public biomedical institution with vaccine, serum, and biopharma production capabilities. Comparable in cellular-therapy research but broader in scope.

Direct peers

• Universidade Federal de Minas Gerais - Faculdade de Medicina: One of Brazil's leading public medical schools with comparable teaching, residency, and biomedical research functions, including strong translational research and a large teaching hospital (Hospital das Clínicas da UFMG).
• Universidade Federal do Rio de Janeiro - Faculdade de Medicina: Another top-tier Brazilian public medical school with parallel undergraduate, graduate, and hospital-based research programs anchored by Hospital Universitário Clementino Fraga Filho, comparable in scale and mission to FMRP.
• Children's Hospital of Philadelphia (CHOP) - Center for Cellular Immunotherapies: Pioneer academic center for CAR-T therapy development, originating Kymriah with Novartis. The closest international peer to FMRP's CTC-USP for cellular therapy research and clinical translation.
• Hospital de Clínicas de Porto Alegre (HCPA - UFRGS): University teaching hospital affiliated with UFRGS, comparable in scale and academic mission to FMRP's Hospital das Clínicas, including clinical research and graduate medical training.
• Universidade Federal de São Paulo (UNIFESP) - Escola Paulista de Medicina: A leading Brazilian public medical school with comparable medical education, residency training, and biomedical research portfolio, including Hospital São Paulo as its teaching hospital.
• Faculdade de Medicina da Universidade de São Paulo (FMUSP): The São Paulo-based sister medical school of USP, offering the same medical education, residency, and biomedical research portfolio (including large teaching hospital HC-FMUSP). It is the most direct domestic peer of FMRP within the USP system.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/fmrpusp
• YouTubeyoutube.com/channel/UCnAB5CQKmO-nERmpV8BYv6Q
• Facebookfacebook.com/fmrpusp
• Instagraminstagram.com/fmrp.usp

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Faculdade de Medicina de Ribeirão Preto (FMRP) da USP